Abzena has appointed Jonathan Goldman, MD as chief executive officer, following completion of the Acquisition by Welsh, Carson, Anderson & Stowe (WCAS).

Dr. Goldman will focus his efforts on the growth of Abzena as the leading provider of outsourced and integrated services in the biologics early development space by establishing new partnerships with clients, building internal manufacturing capacity and pursuing strategic acquisitions. He joins the company after achieving significant success as the chief executive officer of Aptuit LLC, a leading global Contract Research Organization that specialized in the provision of discovery, development and manufacturing of small molecules. Aptuit was sold to Evotec in 2017 after 12 years of growth as a WCAS portfolio company.

John Burt will transition out of the chief executive officer role to serve as a senior advisor to the company and member of the management team to guide customer relationships and growth, potentially by merger and acquisition.

Dr. Goldman said, “I’m delighted to join Abzena, and look forward to working closely with the outstanding leadership team to leverage a unique end to end value proposition ranging from antibody discovery to clinical scale GMP biologic drug substance manufacture. We will serve an unmet need for scientific expertise delivered at high quality, low cost and compressed timelines. Abzena is the ideal partner to meet these needs across a comprehensive suite of services. I am very excited to grow the company as the partner of choice for drug developers, with the support of WCAS.”

Dr. Ken Cunningham, chairman of Abzena said, “We’re very pleased that Jonathan is joining us. He brings exceptional experience in the growth of contract services companies providing integrated solutions. We believe his background in executive leadership, science, sales and medicine are needed to progress the company to the next stage. This skillset makes him the perfect complement to our senior management team. We would like to express our profound thanks to John for his immense contribution and vision in growing the company to this point, and for successfully transitioning the company to new ownership.”

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed information about the use of cookies on our website by clicking on "More information”.